Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

764 Press Releases
DateTitleCompany
01 Oct 13 Merck Serono's Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-Type Patients When Compared With Bevacizumab: New Analysis of FIRE-3 AIO Study Merck Serono,
Published by
AxonComms
01 Oct 13 Merck Updates Plans for Headquarters Move in New Jersey Merck,
Published by
Business Wire
27 Sep 13 Merck to Hold Third-Quarter 2013 Sales and Earnings Conference Call on October 28 Merck,
Published by
Business Wire
23 Sep 13 Merck Receives Complete Response Letter for Investigational Medicine Sugammadex Sodium Injection Merck,
Published by
Business Wire
11 Sep 13 Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer Merck,
Published by
Business Wire
10 Sep 13 Merck Millipore Donates $30,000 to charity: water in Recognition of World Water Week Merck Millipore,
Published by
Business Wire
09 Sep 13 Merck Announces FDA Acceptance of New Drug Application for Investigational Fertility Treatment Merck,
Published by
Business Wire
30 Jul 13 Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness Merck,
Published by
Business Wire
24 Jul 13 Merck Announces Fourth-Quarter 2013 Dividend Merck,
Published by
Business Wire
24 Jul 13 Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine Merck,
Published by
Business Wire
16 Jul 13 Merck Statement on FDA Advisory Committee Meeting About Sugammadex Sodium Injection Merck,
Published by
Business Wire
01 Jul 13 Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia Merck,
Published by
Business Wire
28 Jun 13 Merck to Hold Second-Quarter 2013 Sales and Earnings Conference Call on July 30 Merck,
Published by
Business Wire
03 Jun 13 Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013 Merck,
Published by
Pharmiweb.com
30 May 13 Merck to Present at the Sanford C. Bernstein Strategic Decisions Conference Merck,
Published by
Business Wire
28 May 13 Merck Announces Third-Quarter 2013 Dividend Merck,
Published by
Business Wire
24 May 13 Merck Prices $ 6.5 Billion Debt Offering Merck & Co. Inc.,
Published by
Business Wire
24 May 13 Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet Merck,
Published by
Business Wire
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
30 Apr 13 Merck Wins FOSAMAX® (alendronate sodium) Federal Bellwether Trial Involving Atypical Femur Fracture Claims Merck,
Published by
Business Wire
01 May 13 Merck Announces New $15 Billion Share Repurchase Program Merck,
Published by
Business Wire
01 Apr 13 Merck to Hold First-Quarter 2013 Sales and Earnings Conference Call on May 1 Merck,
Published by
Business Wire
12 Apr 13 Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole) Merck
22 Apr 13 Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C Merck,
Published by
Business Wire
24 May 13 Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference Merck,
Published by
Business Wire
24 May 13 Merck to Present at the UBS Global Healthcare Conference Merck,
Published by
Business Wire
24 May 13 Merck Announces $5 Billion Accelerated Share Repurchase Merck,
Published by
Business Wire
24 May 13 Merck Statement on FDA Advisory Committee Meeting for Suvorexant Merck,
Published by
Business Wire
24 May 13 Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.